Coherent Market Insights published a business research report on Chemiluminescence Immunoassay Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Chemiluminescence Immunoassay Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4656
Chemiluminescence is the method of transforming chemical energy into visible light that is emitted as the result of chemical reaction (oxidation or hydrolysis). This method provides cost-effective and sensitive search methods to many radio-isotopic and fluorescence methods and most chromogenic detection processes. Chemiluminescence imaging is the process of capturing a series of images at the time of identification of less abundant proteins. Chemiluminescent imaging enables accurate validation of Western blots with a real-time display.
The global chemiluminescence immunoassay market is expected to record a CAGR of 8.0 % during 2021-2028 and was estimated to be valued at US$ 6.01 billion in 2021.
Global Chemiluminescence Immunoassay Market: Drivers
Approval and launch of new products is expected to propel growth of the global chemiluminescence immunoassay market over the forecast period. For example, in July 2021, Sysmex Europe GmbH launched the automated blood coagulation analyzers CN-3500 and CN-6500, in specific EMEA countries.
Moreover, high prevalence of infectious diseases is also expected to propel growth of the global chemiluminescence immunoassay market over the forecast period. For example, 36,801 people were diagnosed with HIV in 2019 in the U.S, according to the Centers for Disease Control and Prevention. Moreover, around 1,189,700 people in the U.S. were diagnosed with HIV and 15,815 deaths were reported due to the disease in the U.S.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4656
Global Chemiluminescence Immunoassay Market: Covid-19 Impact Analysis
R&D in Covid-19 using chemiluminescent immunoassay is expected to offer lucrative growth opportunities for players in the global chemiluminescence immunoassay market. For example, in January 2021, a study published by Yokohama City University Hospital and Kanagawa Cardiovascular & Respiratory Center, in collaboration with Japan Agency for Medical Research and Development, reported development of an automated Chemiluminescence Assay System to quantitatively measure multiple anti-SARS-CoV-2 antibodies.
Major players operating in the global chemiluminescence immunoassay market are focused on adopting merger and acquisition strategies to expand their product portfolio. For example, in May 2021, PerkinElmer, Inc. acquired Immunodiagnostic Systems Holdings PLC, a manufacturer of in-vitro diagnostic tests.
Global Chemiluminescence Immunoassay Market: Competitive Landscape
Major players operating in the global chemiluminescence immunoassay market include, Abbott Laboratories, DiaSorin S.p.A., Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Ortho Clinical Diagnostic, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, and Tosoh Corporation.
Global Chemiluminescence Immunoassay Market: Segmentation
By Product Type
- Luminophore Markers
- Enzymatic Markers
- Therapeutic Drug Monitoring
- Oncology, Cardiology
- Infectious Disease
- Autoimmune Disease
By End User
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4656
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Chemiluminescence Immunoassay Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Chemiluminescence Immunoassay Industry Impact
Chapter 2 Global Chemiluminescence Immunoassay Competition by Types, Applications, and Top Regions and Countries
2.1 Global Chemiluminescence Immunoassay (Volume and Value) by Type
2.3 Global Chemiluminescence Immunoassay (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Chemiluminescence Immunoassay Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Chemiluminescence Immunoassay Market Analysis
Chapter 6 East Asia Chemiluminescence Immunoassay Market Analysis
Chapter 7 Europe Chemiluminescence Immunoassay Market Analysis
Chapter 8 South Asia Chemiluminescence Immunoassay Market Analysis
Chapter 9 Southeast Asia Chemiluminescence Immunoassay Market Analysis
Chapter 10 Middle East Chemiluminescence Immunoassay Market Analysis
Chapter 11 Africa Chemiluminescence Immunoassay Market Analysis
Chapter 12 Oceania Chemiluminescence Immunoassay Market Analysis
Chapter 13 South America Chemiluminescence Immunoassay Market Analysis
Chapter 14 Company Profiles and Key Figures in Chemiluminescence Immunoassay Business
Chapter 15 Global Chemiluminescence Immunoassay Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027